Top ▲

Bromodomain kinase (BRDK) family

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).


« Hide More detailed introduction

Bromodomain (BRD)-containing kinases initiate acetylation-dependent assembly of transcriptional regulator complexes by binding to (or 'reading') acetyl-lysine marks on histone tails. The regulator complexes thus formed, control expression of sets of proteins which alter the cellular phenotype in specific ways. (BRD)-containing proteins are exciting targets for the development of novel small molecule therapeutics in the areas of cancer, inflammation and viral infection [1].


BRD1 (bromodomain containing 1) Show summary » More detailed page

BRD2 (bromodomain containing 2) Show summary » More detailed page

BRD3 (bromodomain containing 3) Show summary » More detailed page

BRD4 (bromodomain containing 4) Show summary » More detailed page

BRD7 (bromodomain containing 7) Show summary » More detailed page

BRD8 (bromodomain containing 8) Show summary » More detailed page

BRD9 (bromodomain containing 9) Show summary » More detailed page


Show »

How to cite this family page

Database page citation:

Bromodomain kinase (BRDK) family. Accessed on 22/10/2020. IUPHAR/BPS Guide to PHARMACOLOGY,

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. (2019) The Concise Guide to PHARMACOLOGY 2019/20: Enzymes. Br J Pharmacol. 176 Issue S1: S297-S396.